A detailed history of Flavin Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Flavin Financial Services, Inc. holds 1,960 shares of ABBV stock, worth $333,788. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,960
Holding current value
$333,788
% of portfolio
0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$164.99 - $203.87 $323,380 - $399,585
1,960 New
1,960 $348 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Flavin Financial Services, Inc. Portfolio

Follow Flavin Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flavin Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flavin Financial Services, Inc. with notifications on news.